首页 > 最新文献

Casopis lekaru ceskych最新文献

英文 中文
47th conference of the International Society of Oncology and Biomarkers - ISOBM: A new era of biomarkers in oncology. 第47届国际肿瘤和生物标志物学会会议- ISOBM:肿瘤生物标志物的新时代。
Q4 Medicine Pub Date : 2025-01-01
Judita Kinkorová, Ondřej Topolčan

From October 12-16, 2025, the 47th annual International Society of Oncology and Biomarkers (ISOBM) conference was held in Murnau, Bavaria, under the subtitle "New Era of Biomarkers in Oncology". The focus of the conference was the integration of modern technologies in oncology, including biomarker research, molecular diagnostics, and artificial intelligence applications in cancer care. The event welcomed more than 300 participants, 38 exhibitors, and 7 corporate partners from a total of 27 countries. The rich program featured presentations across 17 sessions, panel discussions, 12 workshops, and over 70 posters. The conference thus provided a multidisciplinary platform bringing together laboratory medicine, pathology, molecular biology, clinical oncology, and specialists in data processing and artificial intelligence.

2025年10月12日至16日,第47届国际肿瘤与生物标志物学会(ISOBM)年会在巴伐利亚的Murnau举行,副标题为“肿瘤生物标志物的新时代”。会议的重点是肿瘤学现代技术的整合,包括生物标志物研究、分子诊断和人工智能在癌症治疗中的应用。本次活动共迎来了来自27个国家的300多名参与者、38家参展商和7家企业合作伙伴。会议内容丰富,包括17场会议、小组讨论、12场研讨会和70多张海报。因此,会议提供了一个多学科平台,汇集了检验医学、病理学、分子生物学、临床肿瘤学以及数据处理和人工智能方面的专家。
{"title":"47th conference of the International Society of Oncology and Biomarkers - ISOBM: A new era of biomarkers in oncology.","authors":"Judita Kinkorová, Ondřej Topolčan","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>From October 12-16, 2025, the 47th annual International Society of Oncology and Biomarkers (ISOBM) conference was held in Murnau, Bavaria, under the subtitle \"New Era of Biomarkers in Oncology\". The focus of the conference was the integration of modern technologies in oncology, including biomarker research, molecular diagnostics, and artificial intelligence applications in cancer care. The event welcomed more than 300 participants, 38 exhibitors, and 7 corporate partners from a total of 27 countries. The rich program featured presentations across 17 sessions, panel discussions, 12 workshops, and over 70 posters. The conference thus provided a multidisciplinary platform bringing together laboratory medicine, pathology, molecular biology, clinical oncology, and specialists in data processing and artificial intelligence.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 7-8","pages":"361-363"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence in biobanking: current situation and future perspectives. 人工智能在生物银行中的应用:现状与未来展望
Q4 Medicine Pub Date : 2025-01-01
Judita Kinkorová

Biobanks are essential infrastructures for biomedical research and personalized medicine. The exponential growth of heterogeneous data from various sources (genomics, imaging, electronic health records, environmental data) creates opportunities for artificial intelligence (AI) applications to improve data management, biomarker discovery, laboratory automation, and sample accessibility. This article reviews current trends, technical and ethical challenges, GDPR-related considerations, the role of FAIR (findable, accessible, interoperable, reusable) data principles and federated learning, the importance of explainable AI, and implications for the Czech healthcare system. Practical recommendations for safe and sustainable AI integration into biobanks are provided.

生物银行是生物医学研究和个性化医疗的重要基础设施。来自各种来源(基因组学、成像、电子健康记录、环境数据)的异构数据呈指数级增长,为人工智能(AI)应用程序改善数据管理、生物标志物发现、实验室自动化和样本可访问性创造了机会。本文回顾了当前趋势、技术和伦理挑战、与gdp相关的考虑因素、FAIR(可查找、可访问、可互操作、可重用)数据原则和联邦学习的作用、可解释人工智能的重要性以及对捷克医疗保健系统的影响。提出了将人工智能安全、可持续地融入生物库的实用建议。
{"title":"Artificial intelligence in biobanking: current situation and future perspectives.","authors":"Judita Kinkorová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Biobanks are essential infrastructures for biomedical research and personalized medicine. The exponential growth of heterogeneous data from various sources (genomics, imaging, electronic health records, environmental data) creates opportunities for artificial intelligence (AI) applications to improve data management, biomarker discovery, laboratory automation, and sample accessibility. This article reviews current trends, technical and ethical challenges, GDPR-related considerations, the role of FAIR (findable, accessible, interoperable, reusable) data principles and federated learning, the importance of explainable AI, and implications for the Czech healthcare system. Practical recommendations for safe and sustainable AI integration into biobanks are provided.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 7-8","pages":"328-332"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Change in the prevalence of overweight, obesity and severe obesity in seven-year-old children between 2019-2023 - project COSI. 2019-2023年期间7岁儿童超重、肥胖和严重肥胖患病率的变化——COSI项目
Q4 Medicine Pub Date : 2025-01-01
Tereza Metelcová, Tereza Svobodová, Marie Kunešová, Radka Taxová Braunerová, Markéta Vaňková

This study is part of the World Health Organization's European initiative to monitor trends in overweight and obesity in children. Children have been monitored every two years using a consistent protocol since 2008. The COVID-19 pandemic (2019-2021) and related restrictions significantly altered daily life, including that of children. We compared the prevalence of overweight in seven-year-olds from the 5th monitoring period (Jan-Dec 2019) and the 6th period (Nov 2022-Mar 2024) to assess the impact of pandemic-related restrictions. Results showed no significant change in overall overweight or obesity prevalence between the two periods. In the 6th monitoring, 5.7% of boys and 6% of girls had overweight; 7.5% of boys and 7.3% of girls had obesity. Severe obesity was relatively high (3.8% for both sexes) but not significantly different from 2019. Abdominal obesity, indicated by a risk waist-to-height ratio, was found in 12.9% of boys and 12.2% of girls - also unchanged from the earlier monitoring. Overall, two years after lifting COVID-19 restrictions, overweight prevalence in 7-year-olds remained like pre-pandemic levels. However, the persistent prevalence of severe obesity is concerning and highlights the need for continued public health efforts.

这项研究是世界卫生组织监测儿童超重和肥胖趋势的欧洲倡议的一部分。自2008年以来,使用一致的协议每两年监测一次儿童。COVID-19大流行(2019-2021年)和相关限制措施显著改变了包括儿童在内的日常生活。我们比较了第5个监测期(2019年1月至12月)和第6个监测期(2022年11月至2024年3月)7岁儿童的超重患病率,以评估与大流行相关的限制措施的影响。结果显示,在这两个时期,总体超重或肥胖患病率没有显著变化。在第6次监测中,5.7%的男孩和6%的女孩超重;7.5%的男孩和7.3%的女孩肥胖。严重肥胖率相对较高(男女均为3.8%),但与2019年相比没有显著差异。腹部肥胖,即腰高比风险,在12.9%的男孩和12.2%的女孩中被发现,这与早期的监测结果没有变化。总体而言,在取消COVID-19限制两年后,7岁儿童的超重患病率仍与大流行前的水平持平。然而,严重肥胖的持续流行令人担忧,并突出表明需要继续作出公共卫生努力。
{"title":"Change in the prevalence of overweight, obesity and severe obesity in seven-year-old children between 2019-2023 - project COSI.","authors":"Tereza Metelcová, Tereza Svobodová, Marie Kunešová, Radka Taxová Braunerová, Markéta Vaňková","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This study is part of the World Health Organization's European initiative to monitor trends in overweight and obesity in children. Children have been monitored every two years using a consistent protocol since 2008. The COVID-19 pandemic (2019-2021) and related restrictions significantly altered daily life, including that of children. We compared the prevalence of overweight in seven-year-olds from the 5th monitoring period (Jan-Dec 2019) and the 6th period (Nov 2022-Mar 2024) to assess the impact of pandemic-related restrictions. Results showed no significant change in overall overweight or obesity prevalence between the two periods. In the 6th monitoring, 5.7% of boys and 6% of girls had overweight; 7.5% of boys and 7.3% of girls had obesity. Severe obesity was relatively high (3.8% for both sexes) but not significantly different from 2019. Abdominal obesity, indicated by a risk waist-to-height ratio, was found in 12.9% of boys and 12.2% of girls - also unchanged from the earlier monitoring. Overall, two years after lifting COVID-19 restrictions, overweight prevalence in 7-year-olds remained like pre-pandemic levels. However, the persistent prevalence of severe obesity is concerning and highlights the need for continued public health efforts.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 6","pages":"247-251"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145793327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
His dream became reality. In memory of professor Vladimír Vonka (1930-2025). 他的梦想变成了现实。纪念Vladimír冯卡教授(1930-2025)。
Q4 Medicine Pub Date : 2025-01-01
Milan Macek
{"title":"His dream became reality. In memory of professor Vladimír Vonka (1930-2025).","authors":"Milan Macek","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 6","pages":"282-284"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145793332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shooting at the Faculty of Arts of Charles University and activation of the trauma plan at the First Surgical Clinic of the General Teaching Hospital. 查尔斯大学文学院枪击事件与综合教学医院第一外科诊所创伤计划的启动。
Q4 Medicine Pub Date : 2025-01-01
Josef Kraus, Filip Burget

The Trauma Plan is a set of measures to mitigate the consequences of injury in emergencies and crisis situations. It was activated at the First Surgical Clinic of the General University Hospital in December 2023, on the day of the tragic shooting in the building of the Faculty of Arts of Charles University in Prague. Thanks to the practice activations, teams, premises and beds were prepared within 20 minutes without complications. An exceptional case was a gunshot wound that occurred at 350 meters (on the other bank of the Vltava River), the origin of which, however, the patient-foreigner was not aware of and was reported as a fracture of the femur after a fall while fleeing.

创伤计划是在紧急情况和危机情况下减轻伤害后果的一套措施。该系统于2023年12月,即布拉格查尔斯大学文学院大楼发生悲惨枪击事件的当天,在大学总医院第一外科诊所启动。由于实践激活,团队、场地和床位在20分钟内准备就绪,没有出现任何并发症。一个例外的例子是在350米(伏尔塔瓦河对岸)处发生的枪伤,但外籍病人不知道枪伤的来源,据报道是在逃跑时摔倒后股骨骨折。
{"title":"Shooting at the Faculty of Arts of Charles University and activation of the trauma plan at the First Surgical Clinic of the General Teaching Hospital.","authors":"Josef Kraus, Filip Burget","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The Trauma Plan is a set of measures to mitigate the consequences of injury in emergencies and crisis situations. It was activated at the First Surgical Clinic of the General University Hospital in December 2023, on the day of the tragic shooting in the building of the Faculty of Arts of Charles University in Prague. Thanks to the practice activations, teams, premises and beds were prepared within 20 minutes without complications. An exceptional case was a gunshot wound that occurred at 350 meters (on the other bank of the Vltava River), the origin of which, however, the patient-foreigner was not aware of and was reported as a fracture of the femur after a fall while fleeing.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 3","pages":"90-93"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144858963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Newly discovered documents about J. E. Purkyně at the Anatomical Institute of the 1st Faculty of Medicine, Charles University. 查尔斯大学第一医学院解剖研究所新发现的关于J. E. purkynyi的文件。
Q4 Medicine Pub Date : 2025-01-01
Markéta Ivánková
{"title":"Newly discovered documents about J. E. Purkyně at the Anatomical Institute of the 1st Faculty of Medicine, Charles University.","authors":"Markéta Ivánková","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 6","pages":"273-278"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145793353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recommendations for the implementation of European Union regulations on the donation and use of human-derived substances. 关于执行欧洲联盟关于捐赠和使用人类来源物质的条例的建议。
Q4 Medicine Pub Date : 2025-01-01
Hana Konečná

In July 2024, a European Union regulation on substances of human origin came into effect, which is to be implemented into the legislation of member states by August 2027. The fundamental ethical principle remains voluntary and unpaid donation, but the responsibility for addressing related ethical issues is left to the member states. Ethical topics that should be considered during implementation, such as methods of obtaining and compensating donors of substances of human origin, donor anonymity, and the content of informed consents, were addressed in our research project "Quality and Sustainability of Body Part Donation Programs in the Czech Republic - TA ČR No. TL05000144", which took place between 2021 and 2023.

2024年7月,欧盟关于人类来源物质的法规生效,该法规将于2027年8月之前纳入成员国的立法。自愿和无偿捐赠是基本的伦理原则,但解决相关伦理问题的责任由成员国承担。在实施过程中应该考虑的伦理问题,如获取和补偿人体来源物质捐赠者的方法、捐赠者匿名和知情同意的内容,都在我们的研究项目“捷克共和国身体部位捐赠计划的质量和可持续性- TA ČR No. 1”中得到了解决。TL05000144”,发生在2021年至2023年之间。
{"title":"Recommendations for the implementation of European Union regulations on the donation and use of human-derived substances.","authors":"Hana Konečná","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In July 2024, a European Union regulation on substances of human origin came into effect, which is to be implemented into the legislation of member states by August 2027. The fundamental ethical principle remains voluntary and unpaid donation, but the responsibility for addressing related ethical issues is left to the member states. Ethical topics that should be considered during implementation, such as methods of obtaining and compensating donors of substances of human origin, donor anonymity, and the content of informed consents, were addressed in our research project \"Quality and Sustainability of Body Part Donation Programs in the Czech Republic - TA ČR No. TL05000144\", which took place between 2021 and 2023.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 4","pages":"166-168"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146050355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Late-onset hypogonadism in men over 40 - how to use the updated EAU 2025 guidelines and new findings on the cardiovascular safety of testosterone therapy. 40岁以上男性迟发性性腺功能减退——如何使用更新的EAU 2025指南和睾酮治疗心血管安全性的新发现
Q4 Medicine Pub Date : 2025-01-01
Marek Broul, Aneta Hujová

Late-onset hypogonadism is a clinical syndrome defined by androgen-deficiency symptoms and persistently low testosterone; it affects roughly two to eight percent of European men aged 40-79 years and becomes more prevalent with advancing age, obesity and cardiometabolic comorbidities. The 2025 update of the European Association of Urology (EAU) guidelines sets a unified biochemical threshold of total testosterone below 12 nmol/L confirmed by two morning samples and emphasises baseline assessment of luteinizing hormone (LH), follicle-stimulating hormone (FSH), blood pressure and haematocrit before therapy. The large multicentre TRAVERSE trial showed that transdermal testosterone replacement does not increase major adverse cardiovascular events, yet revealed a mild rise in systolic blood pressure, a finding reflected in the latest US Food and Drug Administration (FDA) labelling changes. Building on this evidence, we propose a four-step algorithm encompassing precise diagnosis, judicious initiation of treatment, integrated management of cardiometabolic risk factors and personalised fertility preservation. Such an approach permits effective and safe management of symptomatic late-onset hypogonadism while mitigating long-term risks.

迟发性性腺功能减退症是一种以雄激素缺乏症状和持续低睾酮为特征的临床综合征;在40-79岁的欧洲男性中,大约有2%到8%的人患有此病,随着年龄的增长、肥胖和心脏代谢合并症的出现,此病变得更加普遍。2025年更新的欧洲泌尿外科协会(EAU)指南将总睾酮的统一生化阈值设定为低于12 nmol/L,并通过两个早晨的样本确认,并强调治疗前对黄体生成素(LH)、促卵泡激素(FSH)、血压和红细胞压差的基线评估。大型多中心TRAVERSE试验显示,经皮睾酮替代不会增加主要不良心血管事件,但显示收缩压轻度升高,这一发现反映在最新的美国食品和药物管理局(FDA)标签变化中。基于这一证据,我们提出了一个四步算法,包括精确诊断、明智的治疗起始、心脏代谢危险因素的综合管理和个性化的生育保护。这种方法允许有效和安全的管理症状性迟发性腺功能减退,同时减轻长期风险。
{"title":"Late-onset hypogonadism in men over 40 - how to use the updated EAU 2025 guidelines and new findings on the cardiovascular safety of testosterone therapy.","authors":"Marek Broul, Aneta Hujová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Late-onset hypogonadism is a clinical syndrome defined by androgen-deficiency symptoms and persistently low testosterone; it affects roughly two to eight percent of European men aged 40-79 years and becomes more prevalent with advancing age, obesity and cardiometabolic comorbidities. The 2025 update of the European Association of Urology (EAU) guidelines sets a unified biochemical threshold of total testosterone below 12 nmol/L confirmed by two morning samples and emphasises baseline assessment of luteinizing hormone (LH), follicle-stimulating hormone (FSH), blood pressure and haematocrit before therapy. The large multicentre TRAVERSE trial showed that transdermal testosterone replacement does not increase major adverse cardiovascular events, yet revealed a mild rise in systolic blood pressure, a finding reflected in the latest US Food and Drug Administration (FDA) labelling changes. Building on this evidence, we propose a four-step algorithm encompassing precise diagnosis, judicious initiation of treatment, integrated management of cardiometabolic risk factors and personalised fertility preservation. Such an approach permits effective and safe management of symptomatic late-onset hypogonadism while mitigating long-term risks.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 4","pages":"150-155"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146050315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alcohol-related liver disease. 与酒精有关的肝病。
Q4 Medicine Pub Date : 2025-01-01
Eva Mayerová

Alcohol-related liver disease (ALD) represents a broad continuum of pathological conditions caused by excessive alcohol consumption - from simple steatosis through steatohepatitis and fibrosis to cirrhosis and its complications. The article summarizes the current view on this issue.

酒精相关性肝病(ALD)是由过量饮酒引起的一系列广泛的病理状况——从单纯的脂肪变性到脂肪性肝炎和纤维化,再到肝硬化及其并发症。文章总结了目前对这一问题的看法。
{"title":"Alcohol-related liver disease.","authors":"Eva Mayerová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Alcohol-related liver disease (ALD) represents a broad continuum of pathological conditions caused by excessive alcohol consumption - from simple steatosis through steatohepatitis and fibrosis to cirrhosis and its complications. The article summarizes the current view on this issue.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 7-8","pages":"299-305"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health literacy in international recommendations and studies. 国际建议和研究中的卫生素养。
Q4 Medicine Pub Date : 2025-01-01
Alena Šteflová, Jan Dudra

Health literacy means the ability to acquire, evaluate and apply health-related information. Health literacy affects motivation, health behavior, but also trust in health systems. For the development and improvement of health literacy in the European context, it is necessary to measure health literacy and compare it internationally.

健康素养是指获取、评价和应用健康相关信息的能力。卫生素养影响动机、卫生行为,也影响对卫生系统的信任。为了在欧洲范围内发展和改善卫生素养,有必要衡量卫生素养并在国际上进行比较。
{"title":"Health literacy in international recommendations and studies.","authors":"Alena Šteflová, Jan Dudra","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Health literacy means the ability to acquire, evaluate and apply health-related information. Health literacy affects motivation, health behavior, but also trust in health systems. For the development and improvement of health literacy in the European context, it is necessary to measure health literacy and compare it internationally.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 1","pages":"14-16"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144858947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Casopis lekaru ceskych
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1